Merck receives FDA approval for Dulera for asthma in patients 12 years and older June 28, 2010 No Comments
Dendreon receives FDA approval for Provenge for castrate-resistant prostate cancer April 30, 2010 No Comments
EMA approves combination of Xeloda and oxaliplatin for adjuvant treatment of early colon cancer March 30, 2010 No Comments
RSS